Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)-Reference-Cited by-同舟云学术

Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)

Published:2014-07 Issue:4 Volume:15 Page:258-265
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Bennouna Jaafar,Havel Libor,Krzakowski Maciej,Kollmeier Jens,Gervais Radj,Dansin Eric,Serke Monika,Favaretto Adolfo,Szczesna Aleksandra,Cobo Manuel,Ciuffreda Libero,Jassem Jacek,Nicolini Mario,Ramlau Rodryg,Amoroso Domenico,Melotti Barbara,Almodovar Teresa,Riggi Marcello,Caux Noël-Raphaël,Vaissière Nathalie,Tan Eng-Huat

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Non–small cell lung cancer: clinical practice guidelines in oncology;Ettinger;J Natl Compr Canc Netw,2012

2. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Peters;Ann Oncol,2012

3. GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients;Souquet;Ann Oncol,2002

4. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer;Scagliotti;J Clin Oncol,2002

5. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial;Kelly;J Clin Oncol,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model;Biomolecules and Biomedicine;2023-08-24

2. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain;BMC Pulmonary Medicine;2023-02-21

3. Purification and characterization of pleuroferin, a novel protein with in vitro anti-non-small cell lung cancer activity from the mushroom Pleurotus ferulae lanzi;Process Biochemistry;2022-11

4. Correlations between objective response rate and survival-based endpoints in first-line advanced non-small cell lung Cancer: A systematic review and meta-analysis;Lung Cancer;2022-08

5. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11